1. Home
  2. SGRP vs RGNT Comparison

SGRP vs RGNT Comparison

Compare SGRP & RGNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SPAR Group Inc.

SGRP

SPAR Group Inc.

HOLD

Current Price

$0.69

Market Cap

18.7M

ML Signal

HOLD

RGNT

Regentis Biomaterials Ltd. Ordinary Shares

N/A

Current Price

$3.15

Market Cap

20.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SGRP
RGNT
Founded
1967
2004
Country
United States
Israel
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
18.7M
20.4M
IPO Year
1996
N/A

Fundamental Metrics

Financial Performance
Metric
SGRP
RGNT
Price
$0.69
$3.15
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
12.0K
4.8K
Earning Date
03-31-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$196,814,000.00
N/A
Revenue This Year
$7.22
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.70
$2.80
52 Week High
$1.41
$8.35

Technical Indicators

Market Signals
Indicator
SGRP
RGNT
Relative Strength Index (RSI) 29.97 40.52
Support Level N/A N/A
Resistance Level $0.85 $3.38
Average True Range (ATR) 0.04 0.14
MACD -0.00 0.09
Stochastic Oscillator 8.37 81.89

Price Performance

Historical Comparison
SGRP
RGNT

About SGRP SPAR Group Inc.

SPAR Group Inc is a merchandising and brand marketing services company, providing a broad range of sales-enhancing services to retailers across classes of trade and consumer goods manufacturers and distributors. It also provides a range of services to retailers, consumer goods manufacturers and distributors around the globe. The company divides its operations into three reportable regional segments: Americas, which is comprised of United States, Canada, Brazil and Mexico; Asia-Pacific (APAC), which is comprised of Japan, China, and India; and Europe, Middle East and Africa (EMEA), which is comprised of South Africa. It generates maximum revenue from the Americas.

About RGNT Regentis Biomaterials Ltd. Ordinary Shares

Regentis Biomaterials Ltd is a regenerative medicine company dedicated to developing tissue repair solutions that restore health and enhance the quality of life of patients. It is focused on orthopedic treatments using its Gelrin platform based on degradable hydrogel implants to regenerate damaged or diseased tissue (inflamed cartilage and bone tissue). Gelrin is a hydrogel matrix of polyethylene glycol diacrylate (a polymer involved in tissue engineering) and denatured fibrinogen (a biologically inactivated protein that normally has a role in blood clotting). Its product is GelrinC, a cell-free, off-the-shelf hydrogel that is cured into an implant in the knee for the treatment of painful injuries to articular knee cartilage.

Share on Social Networks: